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Abstract
Background: The diagnosis of typhoid fever is confirmed by culture of Salmonella enterica serotype Typhi (S. typhi). 
However, a more rapid, simpler, and cheaper diagnostic method would be very useful especially in developing 
countries. The Widal test is widely used in Africa but little information exists about its reliability.
Methods: We assessed the performance of the Widal tube agglutination test among febrile hospitalized Tanzanian 
children. We calculated the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 
various anti-TH and -TO titers using culture-confirmed typhoid fever cases as the "true positives" and all other febrile 
children with blood culture negative for S. typhi as the "true negatives."
Results: We found that 16 (1%) of 1,680 children had culture-proven typhoid fever. A single anti-TH titer of 1:80 and 
higher was the optimal indicator of typhoid fever. This had a sensitivity of 75%, specificity of 98%, NPV of 100%, but PPV 
was only 26%. We compared our main findings with those from previous studies.
Conclusion: Among febrile hospitalized Tanzanian children with a low prevalence of typhoid fever, a Widal titer of ≥ 
1:80 performed well in terms of sensitivity, specificity, and NPV. However a test with improved PPV that is similarly easy 
to apply and cost-efficient is desirable.
Background
Salmonella enterica serotype Typhi (S. typhi), the caus-
ative agent of typhoid fever, was calculated to have caused
approximately 200,000 deaths globally in 2000 [1]. The
clinical picture of typhoid fever is nonspecific; confirmed
diagnosis through blood or bone-marrow culture
requires expensive and labor-intensive isolation and iden-
tification of the organism, which may take up to seven
days. A cheap and rapid alternative laboratory test is
desirable, especially for developing country settings
where typhoid fever is a major public health burden.
Various agglutination tests have been developed [2] of
which the Widal method is the oldest and remains the
most widely used. The test was first introduced by F.
Widal in 1896 [2] and is based on a macroscopically visi-
ble serum - mediated agglutination reaction between S.
typhi somatic lipopolysacharide O antigens (TO) and fla-
gellar H antigens (TH). Laboratories in industrialized
countries have stopped performing the assay. In Africa
the Widal test is still widely used [3] because typhoid
fever is perceived to be endemic in the area [3] and the
Widal test is the only rapid diagnostic assay that is avail-
able and affordable. The Widal test is commonly per-
formed when children and adults present with fever to
treatment centers, as few centers have the capacity to
perform micro-bacterial culture [4]. Despite this wide-
spread use, little has been published on its performance
in Africa.
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We assessed the sensitivity, specificity, positive predic-
tive value (PPV), and negative predictive value (NPV) of
the Widal tube agglutination test among Tanzanian chil-
dren hospitalized with febrile illness and compared our
results with those from previous studies.
Methods
Study site and population
The study was conducted as part of a childhood fever sur-
veillance study at T eule Hospital in M uheza district of
Northeastern Tanzania from 2008 to 2009. Muheza dis-
trict is located between the foothills of Kilimanjaro and
the coastal town of Tanga. The area is highly endemic for
Plasmodium falciparum malaria with perennial transmis-
sion and two seasonal peaks [5]. HIV sero-prevalence
among antenatal clinic attendees was about 7% in 2007
[6]. Teule Hospital is a busy 330-bed district-level general
hospital, serving a surrounding population of 277,000. It
has two 35-bed in-patient pediatric wards receiving
approximately 5,000 child admissions per year (2008).
Inclusion Criteria
Children aged 2 months to 14 years were screened for eli-
gibility during study hours from 7am to 7pm, Monday to
Sunday. Children with fever of 3 or more days prior to
admission, or fever of less than 3 days but with at least
one severity criteria (respiratory distress, deep breathing,
respiratory distress in combination with severe pallor,
prostration, capillary refill ≥ 3 seconds, temperature gra-
dient, systolic blood pressure < 70 mm Hg, coma defined
by Glasgow Coma Scale ≤ 10 or Blantyre Coma Scale ≤ 2,
severe jaundice, history of 2 or more convulsions in the
last 24 hours, blood glucose < 3 mmol associated with
clinical signs, neck stiffness, bulging fontanel, or oxygen
saturation < 90%) were recruited into the study. All clini-
cal information was recorded on a standard case record
form. Treatment was provided according to national
guidelines. On admission we collected 3 to 5 milliliters
(ml) of blood (depending on body weight) from each eli-
gible child for the Widal test and a single blood culture.
All clinical procedures were performed by trained study
clinical officers and nurses under the supervision of study
physicians.
Laboratory
Blood for culture was inoculated into BacT/ALERT™
Pediatric-fan bottles (bioMérieux, Marcy l'Etoile, France).
Inoculated blood culture bottles were transported imme-
diately to the hospital laboratory and incubated in the
BacT/ALERT 3 D automated microbial detection system.
Blood cultures were processed according to standard
methods. Colonies with biochemical reactions on API20E
suggestive of Salmonellae were confirmed serologically
by slide and tube agglutination testing using specific O
and H antisera (Becton Dickinson, NJ, USA).
A minimum of 0.5 ml of blood was separated to obtain
serum samples. All serum samples were frozen at -70°C
until Widal testing was done in three batches. Widal test-
ing was performed using standardized TO (IgM and IgG)
and TH (IgG) antigens (Stained Salmonella Antigens kit,
Span Diagnostics, India) according to standard methods
as described on the package insert. In brief, each sample
was diluted to a concentration of 1:40 with 0.9% NaCl in
two separate plastic tubes. A single drop of antigen was
added to the respective tube. Incubation times for both O
and H agglutinations were 16 to 20 hours at 37°C in a
water bath. Evaluation of test results was performed by at
least two lab technicians on an independent basis under
standardized light conditions. If agglutination was
detected in a sample, testing was done on that sample
diluted serially from 1:80 to 1:1280 for both O and H anti-
gens. All laboratory procedures were performed by
trained laboratory technicians under the supervision of
microbiologists. Technicians performing the Widal tests
were blinded to the participants' clinical picture and
blood culture results.
Data management
Case report forms were double-entered into custom-
made data entry programs using MS-Access (Microsoft
Corp.). Data management programs included error,
range, and consistency check programs. Analyses were
performed using EpiInfo v 3.4.3 (Centers for Disease
Control and Prevention, USA) and Stata TM v 10.0 (Stata
Corp., USA).
Definitions and analysis
Fever was defined as stated history or presence of fever of
≥37.5°C. Bacteremia was defined as fever with isolation of
pathogenic bacteria from blood culture. Children with a
febrile illness were classified as follows: those with S.
typhi subsequently isolated from blood culture (group 1),
those with non-Typhi serotypes of S. enterica (NTS) sub-
sequently isolated from blood culture (group 2), those
with pathogenic bacteria other than Salmonellae subse-
quently isolated from blood culture (group 3), and those
whose blood culture yielded no bacterial pathogen (group
4). Malaria status was not considered in the classification.
In areas of high transmission of P. falciparum where indi-
viduals develop immunity from previous episodes of
malaria starting at a young age, asymptomatic para-
sitemia is common and may be detected during febrile
episodes caused by another infection [7,8].
For the primary analysis, sensitivity (true-positive rate)
was defined as the probability that the Widal test result
would be positive when blood culture confirmed that
typhoid fever was present (group 1) and specificity (true-Ley et al. BMC Infectious Diseases 2010, 10:180
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negative rate) was the probability that the Widal test
result would be negative when S. typhi was not isolated
from blood culture (groups 2, 3, and 4). The positive pre-
dictive value was the probability that culture-confirmed
typhoid was present when the test was positive, and the
negative predictive value was the probability that culture-
confirmed typhoid was not present when the test was
negative. Since serological tests detect antibody response
and perform better after a period of time from the onset
of the illness, sensitivity, specificity, PPV, and NPV were
also calculated separately for cases presenting with fever
for 5 days or less and for more than 5 days. Because con-
troversy exists about what is the most appropriate control
group to use [9-11], we conducted a secondary analysis
using two alternative "true-negative" control groups as
follows: those with NTS and other pathogenic bacteria
isolated from blood culture (groups 2 and 3), and those
with pathogenic bacteria other than Salmonellae isolated
from blood culture (group 3).
Comparisons were made using the Chi square or Fish-
ers' Exact test, as appropriate. Sensitivity, specificity, PPV,
and NPV were calculated according to standard methods.
The 95% confidence interval for sensitivity and specificity
was calculated using the Wilson's Score method [12].
Analyses were performed using EpiInfo v 3.4.3 (Centers
for Disease Control and Prevention, USA) and Stata TM v
10.0 (Stata Corp., USA).
Literature review
We conducted a literature review to compare our main
findings with those from previous studies of similar char-
acter. We included studies of the Widal test which were
identified by direct searches of the MEDLINE database
through PubMed. The searches were restricted to publi-
cations from 1993 to date. We also conducted supple-
mentary searches of the references in retrieved articles.
Abstracts were reviewed and if relevant, the article was
included.
Ethics
The fever surveillance was conducted following the prin-
ciples governing biomedical research involving human
subjects. Prior written informed consent was obtained
from the parent or guardian of all study participants. The
study protocol was approved by the National Institute of
Medical Research, Tanzania, and the International Vac-
cine Institute Institutional Review Board.
Results
The flow of patients is shown in Figure 1. A total of 1,706
febrile children were enrolled out of which 26 (1.5%) were
excluded for the following reasons: 19 or 1.1% had no
blood culture done, 6 or 0.4% had no Widal testing done
due to insufficient quantities of sera, and one case or 0.1%
had no blood culture nor Widal testing done. A total of
1,680 (98.5%) samples were included in the analysis.
There were 16 or 1.0% culture-confirmed typhoid fever
cases (group 1), 49 or 2.9% with NTS infection (group 2),
and 113 or 6.7% with non-Salmonella bacteremia (group
3). From 1,502 (89.4%) children, no pathogenic bacteria
were isolated from blood culture (group 4).
We assessed the age distribution and highest anti-TH
and -TO titer by blood culture-confirmed diagnosis
(Table 1). Children with typhoid fever were significantly
older compared to the other groups. Anti-TH agglutina-
tion titers of 1:80 and higher were detected among 12/16
(75.0%) culture-confirmed typhoid fever cases compared
to 7/49 (14.3%) of those with NTS infection, and 1/113
(0.9%) with other bacteremia (p values = 0.001 and <
0.001, respectively). Similarly, anti-TO agglutination
titers of 1:80 and higher were detected among 11/16
(68.8%) cases of typhoid fever compared to 7/49 (14.3%)
of those with NTS infection and 0/113 (0%) with other
bacteremia (p values < 0.001 and < 0.001, respectively).
Primary analysis
We calculated the sensitivity, specificity, PPV, and NPV of
various Widal test cut-offs for the diagnosis of typhoid
fever (Table 2). The sensitivity, specificity, PPV, and NPV
of an anti-TH titer of 1:80 were 75, 98, 26, and 100%,
respectively. The sensitivity, specificity, PPV, and NPV of
Figure 1 Flow of patients. *Species included: Streptococcus pneumo-
nia (n = 11), beta hemolytic Streptococci (n = 10), Staphylococcus au-
reus (n = 5), Haemophilus influenzae type b (n = 26), Escherichia coli (n = 
31), Acinetobacter species (n = 6), Non-fermenters (n = 12), Others: (n = 
5), Haemophilus parainfluenzae (n = 2), and Gram negative rods not 
identified (n = 5). **Species included: Bacillus (n = 22), Diphtheroids (n 
= 7), Micrococcus (n = 9), alpha-hemolytic Streptococcus viridans (n = 
4), coagulase negative Staphylococcus (n = 104), yeast (n = 5), mixed 
bacterial species (n = 4), Gram positive rods not identified (n = 1).
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Table 1: Number and cumulative frequencies of anti-TH and anti-TO levels overall and by blood culture isolates
Highest titer reached; 
Number (%)
All (n = 1,680) Children with culture-confirmed 
typhoid fever (n = 16)
Children with non-Typhi 
serotypes of S. enterica (n = 49)
Children with other pathogenic 
bacteria (n = 113)
Children with no 
pathogenic bacteria 
isolated (n = 1,502)
Median age (Range)* 1.83
(14.81)
7.21
(11.96)
1.58
(6.73)
1.43
(11.83)
1.84
(14.81)
Anti-TH
≥1:640 15 (0.9) 3 (18.8) 5 (10.2) 0 (0) 7 (0.5)
1:320 24 (1.4) 6 (37.5) 6 (12.2) 0 (0) 12 (0.8)
1:160 36 (2.1) 11 (68.8) 7 (14.3) 0 (0) 18 (1.2)
1:80 46 (2.7) 12 (75.0) 7 (14.3) 1 (0.9) 26 (1.7)
1:40 85 (5.1) 12 (75.0) 9 (18.4) 3 (2.7) 61 (4.1)
No agglutination 1,595 (94.9) 4 (25.0) 40 (81.6) 110 (97.3) 1,441 (95.9)
Anti-TO
≥1:640 6 (0.4) 3 (18.8) 2 (4.1) 0 (0) 1 (0.1)
1:320 18 (1.1) 6 (37.5) 3 (6.1) 0 (0) 9 (0.6)
1:160 34 (2.0) 10 (62.5) 6 (12.2) 0 (0) 18 (1.2)
1:80 44 (2.6) 11 (68.8) 7 (14.3) 0 (0) 26 (1.7)
1:40 95 (5.7) 12 (75.0) 10 (20.4) 3 (2.7) 70 (4.7)
No agglutination 1,585 (94.3) 4 (25.0) 39 (79.6) 110 (97.3) 1,432 (95.3)
*P values: Group 1 vs 4 < 0.001; Group 2 vs 4 = 0.209; Group 3 vs 4 = 0.013Ley et al. BMC Infectious Diseases 2010, 10:180
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an anti-TO titer of 1:80 were 69, 98, 25, and 100%, respec-
tively.
We compared the performance of the Widal test
between patients who presented with fever of 5 days or
less and those who presented with more than 5 days of
fever (Table 3). Of the 16 typhoid fever cases, 6 (37.5%)
presented with fever of 5 days or less, and 10 (62.5%) with
more than 5 days of fever. Of the 1,664 children in the
control group, 1,117 (67%) presented with fever of 5 days
or less and 544 (33%) with more than 5 days of fever.
Three control cases, whose fever duration was unknown,
were excluded from the analysis. The sensitivity of an
anti-TH and -TO titer of 1:80 increased, however not sig-
nificantly, from 67% to 80% and 67% to 70%, respectively,
with the longer duration of fever prior to admission (both
p > 0.05). The PPV of an anti-TH and -TO titer of 1:80
increased from 21% to 30% and 19% to 30% (both p >
0.05), respectively, with the longer duration of fever prior
to admission. But the change was also not statistically sig-
nificant.
Secondary analysis
Using different control groups, we compared the result-
ing sensitivity, specificity, PPV, and NPV of a Widal test
cut-off of an anti-TH and -TO titer of ≥1:80 for the diag-
nosis of typhoid fever (Table 4). Changing the control
group had no significant effect on the sensitivity, specific-
ity, and NPV but markedly increased the PPV of an anti-
TH titer of ≥1:80 from 26% to 92% and the PPV of an
anti-TO titer of ≥1:80 from 25% to 100%.
Comparison with earlier studies
We found 4 articles from 3 countries. In this series, the
age group included and prevalence of blood-culture con-
firmed typhoid fever varied considerably. The cut-off titer
used ranged from ≥1:20 to ≥1:200 and the resulting sensi-
tivity, specificity, PPV and NPV varied considerably
(Table 5).
Discussion
We found that a Widal titer of ≥1:80 was the optimal indi-
cator of typhoid fever in our study population. The PPV,
NPV and specificity in the primary analysis was more-or-
less unchanged from the cut-off titers of ≥1:80 to ≥1:320,
whereas the sensitivity was highest at a cut-off titer of
≥1:80. Although the Widal test at this cut-off titer per-
formed relatively well in terms of sensitivity, specificity
and NPV, its PPV was low. It has been argued that PPV is
the most important measure of a clinical diagnostic
method since it represents the proportion of patients
with positive test results that are correctly diagnosed [13].
The PPV is not intrinsic to the test; it is affected by preva-
lence of the disease. In our setting, where 16 (1%) out of
1,680 febrile patients admitted to the pediatric ward had
culture-proven typhoid fever, a negative Widal test result
would have a good predictive value for the absence of dis-
ease but a positive result would have a low predictive
value for typhoid fever, making the use of the Widal test
in our setting questionable.
In a previous paper describing the clinical aspects of
the children included in this study [14] older age and long
duration of fever were predictive of typhoid fever in this
group.
There are several difficulties associated with evaluation
of the Widal test. Firstly, levels of agglutinins detectable
in the non-infected populations of different areas vary
considerably by time and place depending on the ende-
micity of the disease, which affects test performance. For
example, the sensitivity and specificity of a Widal test
Table 2: Primary analysis for the performance* of the Widal test for typhoid fever diagnosis (n = 1680)
Widal titer Sensitivity (95%CI) Specificity (95%CI) Positive Predictive 
Value
Negative Predictive 
Value
TH ≥1:80 12/16, 0.75
(0.51-0.90)
1630/1664, 0.98
(0.97-0.99)
12/46, 0.26 1630/1634, 1.00
TH ≥1:160 11/16, 0.69
(0.44-0.86)
1639/1664, 0.98
(0.98-0.99)
11/36, 0.31 1639/1644, 1.00
TH ≥1:320 6/16, 0.38
(0.18-0.61)
1646/1664, 0.99
(0.98-0.99)
6/24, 0.25 1646/1656, 0.99
TO ≥1:80 11/16, 0.69
(0.44-0.86)
1631/1664, 0.98
(0.97-0.99)
11/44, 0.25 1631/1636, 1.00
TO ≥1:160 10/16, 0.63
(0.39-0.82)
1640/1664, 0.99
(0.98-0.99)
10/34, 0.29 1640/1646, 1.00
TO ≥1:320 6/16, 0.38
(0.18-0.61)
1652/1664, 0.99
(0.99-1.00)
6/18, 0.33 1652/1662, 0.99
*The values were calculated using culture-confirmed typhoid fever cases (group 1; n = 16) as the true positives and those cases from which 
S. typhi were not isolated from blood culture (groups 2, 3, and 4; n = 1664) as the true negatives.Ley et al. BMC Infectious Diseases 2010, 10:180
http://www.biomedcentral.com/1471-2334/10/180
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anti-TO titer of 1:80 in Kolkata, India was 58% and 85%
[10] compared to our findings of 69% and 98%. Secondly,
test performance is also affected by cross-reacting infec-
tions. In our study, none of the 113 children with non-
Salmonella  bacteremia exhibited titers above 1:80 for
both O and H, although cross-reactions with Klebsiella
spp. and Staphylococcus aureus [15] have been reported.
In contrast, 7 (14.3%) of the 49 children with NTS had
titers above 1:80 for both O and H. There is also the pos-
sibility of cross-reactivity with non-bacterial infections
such as malaria, dengue, hepatitis A, and infectious
mononucleosis [2,9,16]. The third limitation is the choice
of a satisfactory gold standard for diagnosis. We used
blood culture-positive patients as our true positives.
Although bone marrow culture would be the ideal gold
standard, this test is difficult to perform in small rural
hospitals in Africa. We found that 26 (1.7%) of 1,502 chil-
dren from whom pathogenic bacteria were not isolated
showed agglutination at 1:80 or higher, both for O and H
antigens. These may be Widal false positive results due to
cross-reaction. Alternatively, since the reported sensitiv-
ity of a single blood culture is only 40% to 60% [16-19],
some of these are likely to be false negative blood culture
results. The final, and what we found to be the most con-
tentious issue, is the selection of the most appropriate
control group. It is difficult to choose patients with febrile
illness who are blood culture-negative and who definitely
do not have typhoid fever. Furthermore, there were rela-
tively few hospitalized children with no bacteremia in the
same age range as those with typhoid fever. Thus, the
control children were significantly younger than the
cases. For our primary analysis, we used groups 2, 3 and 4
Table 3: Comparison of the performance* of the Widal test for typhoid fever diagnosis by number of days of fever** prior to admission
Widal titer Sensitivity 
(95%CI)
Specificity (95%CI) Positive Predictive 
Value
Negative Predictive Value
≤ 5 days fever (n = 1123)
TH ≥1:80 4/6, 0.67
(0.30-0.90)
1102/1117, 0.99
(0.98-0.99)
4/19, 0.21 1102/1104, 1.00
TH ≥1:160 3/6, 0.50
(0.19-0.81)
1106/1117, 0.99
(0.98-0.99)
3/14, 0.21 1106/1109, 1.00
TH ≥1:320 2/6, 0.33
(0.10-0.70)
1110/1117, 0.99
(0.99-1.00)
2/9, 0.22 1110/1114, 1.00
TO ≥1:80 4/6, 0.67
(0.30-0.90)
1100/1117, 0.98
(0.98-0.99)
4/21, 0.19 1100/1102, 1.00
TO ≥1:160 3/6, 0.50
(0.19-0.81)
1107/1117, 0.99
(0.98-1.00)
3/13, 0.23 1107/1110, 1.00
TO ≥1:320 1/6, 0.17
(0.03-0.56)
1112/1117, 1.00
(0.99-1.00)
1/6, 0.17 1112/1117, 1.00
> 5 days fever (n = 554)
TH ≥1:80 8/10, 0.80
(0.49-0.94)
525/544, 0.97
(0.95-0.98)
8/27, 0.30 525/527, 1.00
TH ≥1:160 8/10, 0.80
(0.49-0.94)
530/544, 0.97
(0.96-0.98)
8/22, 0.36 530/532, 1.00
TH ≥1:320 4/10, 0.40
(0.17-0.69)
533/544, 0.98
(0.96-0.99)
4/15, 0.27 533/539, 0.99
TO ≥1:80 7/10, 0.70
(0.40-0.89)
528/544, 0.97
(0.95-0.98)
7/23, 0.30 528/531, 0.99
TO ≥1:160 7/10, 0.70
(0.40-0.89)
530/544, 0.97
(0.96-0.98)
7/21, 0.33 530/533, 0.99
TO ≥1:320 5/10, 0.50
(0.24-0.76)
537/544, 0.99
(0.97-0.99)
5/12, 0.42 537/542, 0.99
*The values were calculated using culture-confirmed typhoid fever cases (group 1; n = 16) as the true positives and those cases from which 
S. typhi were not isolated from blood culture (groups 2, 3, and 4; n = 1664) as the true negatives. **Three patients whose fever duration was 
unknown were excluded from the analysis.Ley et al. BMC Infectious Diseases 2010, 10:180
http://www.biomedcentral.com/1471-2334/10/180
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(i.e., all children admitted for a febrile illness who were
subsequently culture-negative for S. typhi). These would
be the most conservative controls for specificity since
blood culture picks up only a fraction of typhoid cases,
resulting in a control group that is likely contaminated
with culture-negative typhoid cases. Despite this, the
specificity of the Widal test was high. Using the more
exclusive control groups as others had done previously
[9-11] did not appreciably alter the sensitivity, specificity,
and NPV but they increased the PPV.
The previous studies included in our review (Table 5)
had not been performed in Africa hence different cut - off
titers were applied, and the resulting sensitivity, specific-
ity, PPV and NPV varied considerably. PPV as well as
NPV are dependent on the prevalence of disease within
the group of participants; the selection process of study
participants has therefore direct influence on the results.
The difficulty of choosing the correct control group has
been noted earlier [9]. While the gold standard, blood
culture, is applied in most studies, the true negatives may
be defined as febrile patients with a non-typhi laboratory-
confirmed diagnosis as done by Parry et al. and Olsen et
al. [9,20]. Alternatively, some studies use healthy controls.
Choo et al [21]. considered all febrile cases with an
S.typhi negative blood culture as the control group which
is problematic as a number of blood culture-negative
results are likely to be false-negative due to the poor sen-
sitivity of the blood culture [17-19,22]. Furthermore, it is
difficult to compare the different test kits, as varying anti-
gens perform differently [23].
Conclusion
In summary, a Widal titer of ≥ 1:80 performed relatively
well in terms of sensitivity and specificity. However, the
low prevalence of typhoid fever of approximately 1%
amongst children at Teule Hospital meant that the Widal
test was only useful for excluding the disease.
Considering the low cost of Widal testing and the
absence of comparably cheap tests, Widal testing is likely
to remain the test of choice in many developing country
settings. But the need for rapid and cheap diagnostic
tools with superior performance remains high.
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Table 4: Secondary analysis of the performance of a Widal anti-TH and -TO titer of ≥1:80 for typhoid fever diagnosis using group 1 as true 
positives and three different control groups as true negatives*
Control group Sensitivity (95%CI) Specificity (95%CI) Positive Predictive Value Negative Predictive Value
TH titer ≥1:80:
Groups 2, 3, and 4 
(n = 1664)
12/16, 0.75
(0.51-0.90)
1630/1664, 0.98
(0.97-0.99)
12/46, 0.26 1630/1634,
1.00
Groups 2 and 3 (n 
= 162)
12/16, 0.75
(0.51-0.90)
154/162, 0.95
(0.91-0.97)
12/20, 0.60 154/158, 0.97
Group 3 (n = 113) 12/16, 0.75
(0.51-0.90)
112/113, 0.99
(0.95-1.00)
12/13, 0.92 112/116, 0.97
TO titer ≥1:80:
Groups 2, 3, and 4 
(n = 1664)
11/16, 0.69
(0.44-0.86)
1631/1664, 0.98
(0.97-0.99)
11/44, 0.25 1631/1636,
1.00
Groups 2 and 3 (n 
= 162)
11/16, 0.69
(0.44-0.86)
155/162, 0.96
(0.91-0.98)
11/18, 0.61 155/160, 0.97
Group 3 (n = 113) 11/16, 0.69
(0.44-0.86)
113/113, 1.00
(0.97-1.00)
11/11, 1.00 113/118, 0.96
*Group 1 were those with S. typhi isolated from blood culture (n = 16), group 2 were those with non-typhi serotypes of S. enterica (NTS) isolated 
from blood culture (n = 49), group 3 were those with pathogenic bacteria other than Salmonellae isolated from blood culture (n = 113), and group 
4 were those whose blood culture yielded no bacterial pathogen (n = 1502).L
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Table 5: Summary of Widal performances in earlier studies
Authors Date Study 
Country
Samp
le Size
Age classes 
included
Prevalence 
of S. typhi in 
participants
Sensitivity Specificity PPV NPV Cut Off 
Titer
Control Group(s) Gold 
Standard
Choo et al. 1993 Malaysia 2382 Children 6.1% 89% 89% < 50% 99.2% O or H ≥1:40 Non-typhoid febrile 
children admitted 
to hospital
Blood 
Culture
Parry et al. 1999 Vietnam 2000 Children & 
Adults
30.8% O: 49%
H: 67%;
O or H 
≥1:100:88
%
O: 97%
H: 96%;
O or H ≥1:100:87%
O: 88%
H: 88%;
O or H 
≥1:100:74%
O: 82%
H: 87%;
O or H ≥1:100:94%
O:≥1:200
H: ≥1:100;
O or H 
≥1:100
Lab confirmed 
malaria, dengue or 
bacteremia
Blood 
Culture
Wilke et al. 2002 Turkey 410 ≥18 y 13.2% 52%
Post 7-10 d: 
90%
88%
Post 7-10 d: 90%
76%
Post 7-10 d: 
88%
71%
Post 7-10 d: 93%
O: ≥1:200
H: ≥1:200
Healthy controls, 
nontyphoidal 
febrile patients, 
blood culture 
negative febrile 
cases
Blood 
Culture, 
Stool 
Culture
Olsen et al. 2004 Vietnam 80 ≥3y 73.8% 64% (field)
61% (lab)
76% (field)
100% (lab)
88% (field)
100% (lab)
43% (field)
48% (lab)
O or H 
≥1:100
Lab confirmed 
bacteremia, AFB, 
dengue, malaria, 
pos. stool culture, 
pos. urine culture
Blood 
Culture
Ley et al.T h i s  
study
Tanzania 1680 2 m. - 14y 1% 75% 98% 26% 100% H: ≥1:80 Non-typhoid febrile 
children admitted 
to hospital
Blood 
CultureLey et al. BMC Infectious Diseases 2010, 10:180
http://www.biomedcentral.com/1471-2334/10/180
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